作者: Vincent Donckier , Jean Luc Van Laethem , Serge Goldman , Daniel Van Gansbeke , Pascale Feron
DOI: 10.1002/JSO.10314
关键词: Tumor ablation 、 Malignancy 、 Radiofrequency ablation 、 Metastasis 、 Computed tomography 、 Tumor destruction 、 Medicine 、 Fluorodeoxyglucose positron emission tomography 、 Nuclear medicine 、 FDG-Positron Emission Tomography
摘要: Background and Objectives To assess the value of FDG positron emission tomography (PET) for early detection incomplete tumor destruction after radiofrequency ablation (RFA) liver metastasis. Methods Twenty-eight unresectable metastases in 17 patients were treated by RFA. Patients underwent computed (CT) FDG-PET preoperatively, at 1 week, month, 3 months postoperatively. Postoperative CT week month analyzed to identify hypervascular hypermetabolic residual tumors RFA site. These results correlated with follow-up and, case reintervention, pathologic results. Results In 24/28 RFA-treated metastases, showed no residues. During follow-up, none these 13 developed local recurrence In four patients, peripheral residue RFA, whereas did not revealed tumor. three persistence viable cells was biopsy-proven reintervention. fourth, subsequent development a recurrence. Conclusions FDG-PET accurately monitors efficacy treatment as it recognizes ablation, detectable on CT. J. Surg. Oncol. 2003;84:215–223. © 2003 Wiley-Liss, Inc.